我要投票 宝宝心语在母婴用品行业中的票数:69
· 外 推 电 报 ·
2025-01-21 06:39:00 星期二

【宝宝心语是哪个国家的品牌?】

宝宝心语是什么牌子?「宝宝心语」是深圳市迈健医疗设备有限公司旗下著名品牌。该品牌发源于广东省深圳市,由创始人胡建军在2010-04-22期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

深圳市迈健医疗设备有限公司位于风景秀丽的桃花源科技创新园,毗邻广深高速,交通便利。公司是一家专业从事研发、生产、销售医疗设备的企业,目前公司正邀请国内外各大医院的妇产科专家及中华医学会一起承办“中国孕妇网.中国”主题网站,期待着通过“中国孕妇网.中国”向广大用户提供更多的服务。

“迈健” 的前身多年来一直为国内外数家的医疗设备企业提供OEM服务,积累了长达8年的生产经验,炼就了精良的品质控制水平和高超的软件及电子设计技术。公司目前主要有超声胎音仪、胎儿监护仪、母胎监护仪、多参数病人监护仪、心电图机、妇产综合康复系统等产品。公司拥有专业的医疗和技术研发团队,专业涉及医疗、妇产科、电子、机械、嵌入式系统等,公司获得了中国CMD质量管理体系认证、欧盟产品安全CE认证、中国国家强制性3C认证。产品严格执行ISO13485 医疗器械质量管理体系,为生产 “ 安全、稳定 ” 的医疗器械产品提供了保障。

为了更好的提供优质的产品和专业贴心的服务,“迈健”还与香港大学、中山医科大学、电子科技大学、西安交通大学等多所国内院校签订了科研合作和人才培养协议,为清华大学博士生社会实践接收单位,依托各院校强大的科研实力和人才优势,建立了一支专业的研发设计、生产、品质、销售服务团队。公司拥有多项自主知识产权,现拥有12项专利技术,正保持每年5个以上专利的增长速度;并与国内7家医院的临床专家一起,进行临床试验,根据临床反馈及专家的意见不断修正设计参数。

目前,公司正准备斥巨资进一步扩大深圳生产基地规模(现生产区面积为850平方米,3条自动生产线),以保障达到年产量30万台的产能。 公司拥有世界专业水平的生产设备和检测设备,在注重产品质量和效益的同时,更注重完善的售后服务和不断的产品升级。

“迈健”拥有全球80多个国家和中国25个省市地区经销商的全球营销网络,产品远销欧洲、东南亚、南亚、中东、非洲、拉美等地区,深受各国经销商、医院、科研院校、家庭用户的厚爱。


英文翻译:Shenzhen Maijian Medical Equipment Co., Ltd. is located in the beautiful Taohuayuan science and Technology Innovation Park, adjacent to Guangzhou Shenzhen Expressway, with convenient transportation. The company is a professional enterprise engaged in research and development, production and sales of medical equipment. At present, the company is inviting experts in gynecology and obstetrics from major hospitals at home and abroad and the Chinese Medical Association to jointly undertake the website of "China maternity network. China", looking forward to providing more services to users through "China maternity network. China". The predecessor of "Maijian" has been providing OEM services for several medical equipment enterprises at home and abroad for many years, accumulating up to 8 years of production experience, refining excellent quality control level and superb software and electronic design technology. At present, the company mainly has ultrasonic fetal sound instrument, fetal monitor, maternal fetal monitor, multi parameter patient monitor, electrocardiograph, maternity comprehensive rehabilitation system and other products. The company has a professional medical and technical research and development team, specialized in medical, obstetrics and Gynecology, electronics, machinery, embedded systems, etc. the company has obtained China's CMD quality management system certification, EU product safety CE certification, China's compulsory 3C certification. The product strictly implements the ISO13485 quality management system of medical devices, providing guarantee for the production of "safe and stable" medical device products. In order to better provide high-quality products and professional services, "Maijian" has also signed scientific research cooperation and talent training agreements with many domestic universities, such as Hong Kong University, Zhongshan Medical University, University of Electronic Science and technology, Xi'an Jiaotong University, etc. it has established a professional for the receiving unit of Tsinghua University's doctoral social practice, relying on the strong scientific research strength and talent advantages of each university R & D design, production, quality, sales and service team. The company has a number of independent intellectual property rights, now has 12 patent technologies, and is maintaining the growth rate of more than 5 patents every year. It also conducts clinical trials with clinical experts from 7 domestic hospitals, and constantly modifies design parameters according to clinical feedback and expert opinions. At present, the company is preparing to spend a lot of money to further expand the scale of Shenzhen production base (the current production area is 850 square meters, three automatic production lines), so as to guarantee the annual production capacity of 300000 sets. The company has world-class professional production equipment and testing equipment. While focusing on product quality and efficiency, it also pays more attention to perfect after-sales service and continuous product upgrading. "Maijian" has a global marketing network of dealers in more than 80 countries and 25 provinces and regions in China. Its products are exported to Europe, Southeast Asia, South Asia, the Middle East, Africa, Latin America and other regions, and are deeply loved by dealers, hospitals, research institutions and family users in various countries.

本文链接: https://www.waitui.com/brand/f6b15ba08.html 联系电话:13528427221

千城特选小程序码

7×24h 快讯

双环传动:2024年净利润同比预增24.45%—26.9%

36氪获悉,双环传动发布业绩预告,预计2024年归属于上市公司股东的净利润10.16亿元—10.36亿元,同比增长24.45%—26.9%。

39分钟前

何立峰:大力实施城市更新,有力有序有效推进城市更新重点任务

全国城市更新工作部署视频会议20日在京召开,中共中央政治局委员、国务院副总理何立峰出席会议并讲话。何立峰指出,实施城市更新必须科学制定城市更新专项规划,坚持一张蓝图绘到底、干到底,做到资金和要素跟着项目走,项目跟着规划走。要讲究策略方法,坚持尽力而为、量力而行,先急后缓、有力有序,合理适用、因地制宜,科学确定改造目标和标准,让群众舒适舒心。要落实项目资金平衡责任,按照市场化、法治化原则,统筹利用各方面资金资源,构建好政府、市场与住户之间的资金共担机制。要坚持不动则已、动则必快、动则必成,按期高质量完成项目建设,确保把好事办好、实事办实。要加强组织保障,城市政府应切实承担好主体责任,精心谋划组织,务实推进城市更新项目实施,确保工程质量安全,中央有关部门要加强政策支持,共同推动城市更新工作取得实效。(新华社)

39分钟前

奥来德:拟5000万元-1亿元回购公司股份

36氪获悉,奥来德发布公告,公司计划以自有资金及专项贷款,通过集中竞价方式回购股份,回购资金总额不低于5000万元(含),不超过1亿元(含),回购价格不超过33元/股(含)。中国工商银行股份有限公司吉林省分行提供的股票回购专项贷款不超过7200万元。回购股份将全部用于员工持股计划或股权激励。

39分钟前

百花医药:2024年净利润预增177.56%到254.66%

36氪获悉,百花医药发布公告,预计2024年度实现归属于上市公司股东的净利润3600万元至4600万元,同比增加177.56%到254.66%。

39分钟前

艾力斯:2024年净利润预增121.99%

36氪获悉,艾力斯发布公告,预计2024年度实现归属于母公司所有者的净利润为14.3亿元,同比增加121.99%。

39分钟前

本页详细列出关于一片爽的品牌信息,含品牌所属公司介绍,一片爽所处行业的品牌地位及优势。
咨询